3 results
Approved WMORecruiting
To investigate whether tPRF has an effect on the specific tumor marker of a specific tumor type in a patient with advanced cancer.
Approved WMORecruiting
The purpose of this study is to evaluate the safety and efficacy of two doses of the study drug CT1812 per day for six months in subjects with mild to moderate Alzheimer's disease. CT1812 will be compared with a placebo. A placebo is a product…
Approved WMORecruiting
To assess whether ADRB2 genotype-guided asthma treatment in children with persistend athma symptoms despite ICS treatment leads to better asthma control compared to non-genotype-guided asthma treatment.